MUSUMECI, FRANCESCA MICHELA

MUSUMECI, FRANCESCA MICHELA  

100006 - Dipartimento di Farmacia  

Mostra records
Risultati 1 - 20 di 57 (tempo di esecuzione: 0.036 secondi).
Titolo Data di pubblicazione Autore(i) File
A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutant 1-gen-2016 Radi, Marco; Schneider, Ralf; Fallacara, Anna Lucia; Botta, Lorenzo; Crespan, Emmanuele; Tintori, Cristina; Maga, Giovanni; Kissova, Miroslava; Calgani, Alessia; Richters, André; Musumeci, Francesca; Rauh, Daniel; Schenone, Silvia
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors. 1-gen-2013 Mori, M; Tintori, C; Christopher, Rs; Radi, M; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, P; Delle Monache, S; Angelucci, A; Kissova, M; Crespan, E; Maga, G; Botta, M.
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: From in silico screening to cyclodextrin formulation. 1-gen-2012 Radi, M; Evensen, L; Dreassi, E; Zamperini, C; Caporicci, M; Falchi, F; Musumeci, Francesca; Schenone, Silvia; Lorens, Jb; Botta, M.
A1 receptors ligands: past, present and future trends. 1-gen-2010 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Bruno, Olga; Botta, M.
An update on dual Src/Abl inhibitors 1-gen-2012 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Botta, M.
An Update on JAK Inhibitors 1-gen-2019 Musumeci, Francesca; Greco, Chiara; Giacchello, Ilaria; Fallacara, Anna Lucia; Ibrahim, Munjed M; Grossi, Giancarlo; Brullo, Chiara; Schenone, Silvia
Analogs, formulations and derivatives of imatinib: A patent review 1-gen-2015 Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica
Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells 1-gen-2022 Monteleone, Lorenzo; Marengo, Barbara; Musumeci, Francesca; Grossi, Giancarlo; Carbone, Anna; Valenti, Giulia E.; Domenicotti, Cinzia; Schenone, Silvia
ATP-competitive inhibitors of mTOR: an update. 1-gen-2011 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M; Botta, M.
Bcr-Abl tyrosine kinase inhibitors: A patent review 1-gen-2015 Desogus, Andrea; Schenone, Silvia; Brullo, Chiara; Tintori, Cristina; Musumeci, Francesca
Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies 1-gen-2014 Schenone, Silvia; Radi, M; Musumeci, Francesca; Brullo, Chiara; Botta, M.
Click Chemistry, A Potent Tool in Medicinal Sciences 1-gen-2015 Musumeci, Francesca; Schenone, Silvia; Desogus, Andrea; Nieddu, E.; Deodato, D.; Botta, L.
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma. 1-gen-2015 Tintori, C; Fallacara, Al; Radi, M; Zamperini, C; Dreassi, E; Crespan, E; Maga, G; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Richters, A; Gasparrini, F; Angelucci, A; Festuccia, C; Delle Monache, S; Rauh, D; Botta, M.
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction. 1-gen-2014 Zamperini, C; Dreassi, E; Vignaroli, G; Radi, M; Dragoni, S; Schenone, Silvia; Musumeci, Francesca; Valoti, M; Antiochia, R; Botta, M.
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant. 1-gen-2013 Radi, M; Tintori, C; Musumeci, Francesca; Brullo, Chiara; Zamperini, C; Dreassi, E; Fallacara, Al; Vignaroli, G; Crespan, E; Zanoli, S; Laurenzana, I; Filippi, I; Maga, G; Schenone, Silvia; Angelucci, A; Botta, M.
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study. 1-gen-2011 Radi, M; Dreassi, E; Brullo, Chiara; Crespan, E; Tintori, C; Bernardo, V; Valoti, M; Zamperini, C; Daigl, H; Musumeci, Francesca; Carraro, F; Naldini, A; Filippi, I; Maga, G; Schenone, Silvia; Botta, M.
Development of Pyrazolo[3,4- d]pyrimidine Kinase Inhibitors as Potential Clinical Candidates for Glioblastoma Multiforme 1-gen-2020 Greco, C.; Taresco, V.; Pearce, A. K.; Vasey, C. E.; Smith, S.; Rahman, R.; Alexander, C.; Cavanagh, R. J.; Musumeci, F.; Schenone, S.
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment 1-gen-2024 Vagaggini, Chiara; Petroni, Debora; D'Agostino, Ilaria; Poggialini, Federica; Cavallini, Chiara; Cianciusi, Annarita; Salis, Annalisa; D'Antona, Lucia; Francesconi, Valeria; Manetti, Fabrizio; Damonte, Gianluca; Musumeci, Francesca; Menichetti, Luca; Dreassi, Elena; Carbone, Anna; Schenone, Silvia
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 1-gen-2018 Molinari, Alessio; Fallacara, Anna Lucia; Di Maria, Salvatore; Zamperini, Claudio; Poggialini, Federica; Musumeci, Francesca; Schenone, Silvia; Angelucci, Adriano; Colapietro, Alessandro; Crespan, Emmanuele; Kissova, Miroslava; Maga, Giovanni; Botta, Maurizio
Fyn kinase in brain diseases and cancer: the search for inhibitors. 1-gen-2011 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Biava, M; Falchi, F; Botta, M.